259 related articles for article (PubMed ID: 22153697)
1. Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins.
Yashiro T; Nanmoku M; Shimizu M; Inoue J; Sato R
Atherosclerosis; 2012 Feb; 220(2):369-74. PubMed ID: 22153697
[TBL] [Abstract][Full Text] [Related]
2. Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression.
Yang JH; Bang MA; Jang CH; Jo GH; Jung SK; Ki SH
J Nutr Biochem; 2015 Nov; 26(11):1393-400. PubMed ID: 26320675
[TBL] [Abstract][Full Text] [Related]
3. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
5. Deferoxamine stimulates LDLR expression and LDL uptake in HepG2 cells.
Guillemot J; Asselin MC; Susan-Resiga D; Essalmani R; Seidah NG
Mol Nutr Food Res; 2016 Mar; 60(3):600-8. PubMed ID: 26577249
[TBL] [Abstract][Full Text] [Related]
6. Piperine Induces Hepatic Low-Density Lipoprotein Receptor Expression through Proteolytic Activation of Sterol Regulatory Element-Binding Proteins.
Ochiai A; Miyata S; Shimizu M; Inoue J; Sato R
PLoS One; 2015; 10(10):e0139799. PubMed ID: 26431033
[TBL] [Abstract][Full Text] [Related]
7. A novel functional interaction between the Sp1-like protein KLF13 and SREBP-Sp1 activation complex underlies regulation of low density lipoprotein receptor promoter function.
Natesampillai S; Fernandez-Zapico ME; Urrutia R; Veldhuis JD
J Biol Chem; 2006 Feb; 281(6):3040-7. PubMed ID: 16303770
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
[TBL] [Abstract][Full Text] [Related]
9. POSSIBLE REGULATION OF LDL-RECEPTOR BY NARINGENIN IN HEPG2 HEPATOMA CELL LINE.
Bawazeer NA; Choudary H; Zamzami MA; Abdulaal WH; Zeyadi M; ALbukhari A; Middleton B; Moselhy SS
Afr J Tradit Complement Altern Med; 2017; 14(1):278-287. PubMed ID: 28480406
[TBL] [Abstract][Full Text] [Related]
10. Polydatin Improves Glucose and Lipid Metabolisms in Insulin-Resistant HepG2 Cells through the AMPK Pathway.
Hao J; Huang K; Chen C; Liang Y; Wang Y; Zhang X; Huang H
Biol Pharm Bull; 2018; 41(6):891-898. PubMed ID: 29863077
[TBL] [Abstract][Full Text] [Related]
11. Polyphenol-rich black chokeberry (Aronia melanocarpa) extract regulates the expression of genes critical for intestinal cholesterol flux in Caco-2 cells.
Kim B; Park Y; Wegner CJ; Bolling BW; Lee J
J Nutr Biochem; 2013 Sep; 24(9):1564-70. PubMed ID: 23517916
[TBL] [Abstract][Full Text] [Related]
12. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
[TBL] [Abstract][Full Text] [Related]
13. A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation.
Shende VR; Singh AB; Liu J
Biochem J; 2015 Dec; 472(3):275-86. PubMed ID: 26443862
[TBL] [Abstract][Full Text] [Related]
14. Quercetin up-regulates LDL receptor expression in HepG2 cells.
Moon J; Lee SM; Do HJ; Cho Y; Chung JH; Shin MJ
Phytother Res; 2012 Nov; 26(11):1688-94. PubMed ID: 22388943
[TBL] [Abstract][Full Text] [Related]
15. Sterol regulatory element-binding protein-2 negatively regulates low density lipoprotein receptor-related protein transcription.
Llorente-Cortés V; Costales P; Bernués J; Camino-Lopez S; Badimon L
J Mol Biol; 2006 Jun; 359(4):950-60. PubMed ID: 16697011
[TBL] [Abstract][Full Text] [Related]
16. Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK/SREBP-2/PCSK9/LDLR signalling pathway.
Li X; Hu X; Pan T; Dong L; Ding L; Wang Z; Song R; Wang X; Wang N; Zhang Y; Wang J; Yang B
Biomed Pharmacother; 2021 Jan; 133():110802. PubMed ID: 33202286
[TBL] [Abstract][Full Text] [Related]
17. MK-2206, an allosteric inhibitor of AKT, stimulates LDLR expression and LDL uptake: A potential hypocholesterolemic agent.
Bjune K; Sundvold H; Leren TP; Naderi S
Atherosclerosis; 2018 Sep; 276():28-38. PubMed ID: 30025252
[TBL] [Abstract][Full Text] [Related]
18. Regulation of endothelial lipase and systemic HDL cholesterol levels by SREBPs and VEGF-A.
Kivelä AM; Dijkstra MH; Heinonen SE; Gurzeler E; Jauhiainen S; Levonen AL; Ylä-Herttuala S
Atherosclerosis; 2012 Dec; 225(2):335-40. PubMed ID: 23102786
[TBL] [Abstract][Full Text] [Related]
19. Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.
Singh AB; Dong B; Kraemer FB; Xu Y; Zhang Y; Liu J
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2448-2459. PubMed ID: 30354208
[TBL] [Abstract][Full Text] [Related]
20. Blockage of the ERK signaling pathway abrogates the SCAP ligand-induced transcriptional activation of the LDL receptor gene in HepG2 cells.
Abidi P; Zhang F; Li C; Liu J
Int J Mol Med; 2005 Nov; 16(5):779-85. PubMed ID: 16211244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
